Cervical screening for carcinoma: a comparison of cytological and enzyme (6-phosphogluconate dehydrogenase) methods and clinical findings.
- 24 June 1967
- Vol. 2 (5555) , 785-792
- https://doi.org/10.1136/bmj.2.5555.785
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Cervical cytology: its value and limitations.BMJ, 1966
- PHOSPHOGLUCONATE DEHYDROGENASE ESTIMATION IN VAGINAL FLUID IN THE DIAGNOSIS OF CERVICAL CANCERBJOG: An International Journal of Obstetrics and Gynaecology, 1965
- 6-Phosphogluconate Dehydrogenase Activity in Vaginal Fluid: Limitations as a Screening Test for Genital CancerBMJ, 1965
- SOME ASPECTS OF THE EPIDEMIOLOGY OF CERVICAL CANCER.1965
- SCREENING FOR CANCER OF THE CERVIX AT LOCAL AUTHORITY CLINICS IN MANCHESTERThe Lancet, 1965
- The influence of a cytological screening program upon the incidence of invasive squamous cell carcinoma of the cervix in British ColumbiaAmerican Journal of Obstetrics and Gynecology, 1964
- A New Enzyme Test for Gynaecological CancerBMJ, 1962
- Histochemical Demonstration of 6-Phosphogluconate Dehydrogenase in Proliferating and Malignant CellsNature, 1962
- Significance of in situ Carcinoma of the Uterine CervixBMJ, 1962
- ABERDEEN EXPERIENCE IN THE CYTOLOGICAL DETECTION OF UNSUSPECTED CARCINOMA OF THE CERVIXBJOG: An International Journal of Obstetrics and Gynaecology, 1961